Bitonti, R., Demma, F., Rea, M. and Furneri, G. 2022. Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test. AboutOpen. 9, 1 (Nov. 2022), 105–111. DOI:https://doi.org/10.33393/ao.2022.2447.